The Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026, known as the SAFE Drugs Act, is designed to enhance the regulation of compounding pharmacies and outsourcing facilities to ensure the safety and quality of compounded medications tailored for individual patients. The legislation aims to protect public health by improving oversight and accountability in the compounding process. Key provisions of the Act include stricter definitions and reporting requirements for compounding pharmacies.